Artisan Partners Remains ‘Patient’ in Iovance Biotherapeutics (IOVA)
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Posts Tagged ‘NASDAQ:IOVA’
Is Iovance Biotherapeutics, Inc. (IOVA) A Good Stock To Buy?
Is Iovance Biotherapeutics, Inc.
10 Best Biotech Stocks to Buy According to Cathie Wood
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
Is IOVA Stock A Buy or Sell?
With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell...
Cathie Wood’s Top 5 Stock Picks Based on ARK’s Latest Portfolio Update
In this article, we discuss Cathie Wood's top 5 stock picks.
Cathie Wood’s Thoughts on the Future, ARK’s Portfolio and Latest Stock Picks
In this article we will discuss Cathie Wood's latest stock picks and analyze her latest YouTube talk.
5 Best Biotech Stocks to Invest In
Below are the 5 best biotech stocks to invest in according to the billionaire biotech hedge fund manager Joe Edelman.
Is IOVA A Good Stock To Buy Now?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Was The Smart Money Right About Crowding Into Iovance Biotherapeutics, Inc. (IOVA)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a good investment right now.
Hedge Funds Can’t Buy Enough Of Iovance Biotherapeutics, Inc. (IOVA)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Were Hedge Funds Right About Iovance Biotherapeutics, Inc. (IOVA)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Aren’t Done Buying Iovance Biotherapeutics, Inc. (IOVA)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Hedge Funds Have Never Been This Bullish On Iovance Biotherapeutics, Inc. (IOVA)
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least...
How Did Iovance Biotherapeutics, Inc. (IOVA) Perform In Comparison to Hedge Fund Favorites in 2019?
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Iovance Biotherapeutics, Inc. (IOVA)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Hedge Funds Are Dumping Iovance Biotherapeutics, Inc. (IOVA)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Did Hedge Funds Drop The Ball On Iovance Biotherapeutics, Inc. (IOVA) ?
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due to a low interest rate environment...
Here’s What Hedge Funds Think About Iovance Biotherapeutics, Inc. (IOVA)
During the fourth quarter the Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 7 percentage points as investors worried over the possible ramifications of ...
Hedge Fund and Insider Trading News: Fir Tree, Point72 Asset Management L.P., Groupon Inc (GRPN), Magnachip Semiconductor Corp (MX), Novation Companies Inc (NOVC), and More
Fortunes were made on Wall Street betting against sketchy mortgages before the housing bust a decade ago.
Is Iovance Biotherapeutics, Inc. (IOVA) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Nantahala Capital Management’s Returns, AUM, and Holdings
Nantahala Capital Management is a New Haven-based hedge fund founded in 2004 by 26-year-old Wilmot Harkey.
Market Movers Today: Iovance Biotherapeutics Inc (IOVA), Key Technology, Inc. (KTEC), Union Pacific Corporation (UNP), and More
What happened: Shares of pre-revenue biopharma Iovance Biotherapeutics (NASDAQ:IOVA) rose nearly 30% today after the company announced preliminary results from two phase 2 trials...
